Biology Reference
In-Depth Information
Poespoprodjo, J.R., Fobia, W., Kenangalem, E., Lampah, D.A., Warikar, N., et al., 2008.
Adverse pregnancy outcomes in an area where multidrug-resistant
Plasmodium vivax
and
Plasmodium falciparum
infections are endemic. J. Infect. Dis. 46, 1374-1381.
Poespoprodjo, J.R., Fobia, W., Kenangalem, E., Lampah, D.A., Hasanuddin, A., et al.,
2009. Vivax malaria: a major cause of morbidity in early infancy. Clin. Infect. Dis.
48, 1704-1712.
Poravuth,Y., Socheat, D., Rueangweerayut, R., Uthaisin, C., Pyae Phyo, A., et al., 2011. Pyro-
naridine-artesunate versus chloroquine in patients with acute
Plasmodium vivax
malaria:
a randomized, double-blind, non-inferiority trial. PLoS ONE 6, e14501.
Powell, R.D., Brewer, G.J., 1967. The effects of pyrimethamine, chloroquine, and primaquine
against exoerythrocytic forms of a strain chloroquine-resistant
Plasmodium falciparum
from Thailand. Am. J. Trop. Med. Hyg. 16, 693-698.
Price, R.N., Douglas, N.M., 2010. Maximizing the public health benefit of antimalarials.
Lancet Infect. Dis. 10, 654-655.
Price, R., Nosten, F., Simpson, J.A., Luxemburger, C., Phaipun, L., et al., 1999. Risk factors
for gametocyte carriage in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg.
60, 1019-1023.
Price, L., Planche, T., Rayner, C., Krishna, S., 2007a. Acute respiratory distress syndrome in
Plasmodium vivax
malaria: case report and review of the literature. Trans. R. Soc. Trop.
Med. Hyg. 101, 655-659.
Price, R.N., Tjitra, E., Guerra, C.A., Yeung, S., White, N.J., et al., 2007b. Vivax malaria:
neglected and not benign. Am. J. Trop. Med. Hyg. 77, 79-87.
Price, R.N., Douglas, N.M., Anstey, N.M., 2009. New developments in
Plasmodium vivax
malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 22,
430-435.
Price, R.N., Marfurt, J., Chalfein, F., Kenangalem, E., Piera, K.A., et al., 2010. In vitro activity
of pyronaridine against multidrug-resistant
Plasmodium falciparum
and
Plasmodium vivax
.
Antimicrob. Agents Chemother. 54, 5146-5150.
Pukrittayakamee, S., Chantra, A., Vanijanonta, S., White, N.J., 1998. Pulmonary oedema in
vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 92, 421-422.
Pukrittayakamee, S., Chantra, A., Simpson, J.A., Vanijanonta, S., Clemens, R., et al., 2000.
Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob.
Agents Chemother. 44, 1680-1685.
Ratcliff, A., Siswantoro, H., Kenangalem, E., Maristela, R., Wuwung, R.M., et al., 2007a. Two
fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in
Papua, Indonesia: an open-label randomised comparison. Lancet 369, 757-765.
Ratcliff, A., Siswantoro, H., Kenangalem, E., Wuwung, M., Brockman, A., et al., 2007b. Ther-
apeutic response of multidrug-resistant
Plasmodium falciparum
and
P. vivax
to chloroquine
and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. Soc. Trop. Med.
Hyg. 101, 351-359.
Rieckmann, K.H., Davis, D.R., Hutton, D.C., 1989.
Plasmodium vivax
resistance to chloro-
quine?. Lancet 2, 1183-1184.
Rijken, M.J., Boel, M.E., Russell, B., Imwong, M., Leimanis, M.L., et al., 2011. Chloroquine
resistant vivax malaria in a pregnant woman on the western border of Thailand. Malar.
J. 10, 113.
Rocco, F., 2004. Quinine: Malaria and the Quest for a Cure that Changed the World. Harper
Perennial, New York 384 pp.
Rombo, L., Ericsson, O., Alván, G., Lindström, B., Gustafsson, L.L., et al., 1985. Chloroquine
and desethylchloroquine in plasma, serum, and whole blood: problems in assay and han-
dling of samples. Ther. Drug. Monit. 7, 211-215.
Rossan, R.N.,Young, M.D., Baerg, D.C., 1975. Chemotherapy of
Plasmodium vivax
in Saimiri
and Aotus models. Am. J. Trop. Med. Hyg. 24, 168-173.
